An Outcomes Study to Determine the Reasons Patients on Biologic Therapy Discontinue Treatment and Fail to Follow-up With Their Providers

Psoriasis Treatment Center of Central New Jersey

Status: Completed

Conditions: Psoriasis

Treatments: Drug: Biologic Agent

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT03964168

PTC05

Details and patient eligibility

About

Patient interviews to evaluate the reason patients discontinue biologic therapy and/or fail to follow up with provider.

Full description

Retrospective chart review and patient interviews to evaluate the reason patients discontinue biologic therapy and/or fail to follow up with provider. This research intends to improve the continuity of care by determining why patients stop therapy and what can be done to improve their experience with the provider, pharmaceutical companies and specialty pharmacies.

Enrollment: 3 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Male or female adults ≥ 18 years of age.
• Was receiving first or second biologic therapy
• Has not had a follow up with treating physician in ≥ 9 months

Exclusion criteria

• Actively receiving biologic therapy

  • Was not receiving first or second biologic therapy

Trial design

3 participants in 1 patient group

Biologic Therapy

Description:

Patient's who received and discontinued a biologic therapy

Treatment:

Drug: Biologic Agent